Kazuhiko Yamamoto Selected Research

Kazuhiko Yamamoto Research Topics

Disease

95	Rheumatoid Arthritis 11/2023 - 09/2002
41	Autoimmune Diseases (Autoimmune Disease) 02/2024 - 02/2002
28	Inflammation (Inflammations) 01/2019 - 03/2002
26	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2024 - 09/2004
22	Neoplasms (Cancer) 07/2023 - 08/2002
17	Arthritis (Polyarthritis) 01/2021 - 11/2003
11	Squamous Cell Carcinoma of Head and Neck 09/2022 - 03/2007
11	Experimental Arthritis 04/2016 - 06/2005
11	Asthma (Bronchial Asthma) 02/2016 - 01/2003
9	Infections 07/2023 - 09/2007
7	Eosinophilia 09/2013 - 10/2003
5	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 01/2013
5	Disease Progression 06/2018 - 10/2008
4	Lymphoma (Lymphomas) 01/2024 - 01/2004
4	Melanoma (Melanoma, Malignant) 02/2023 - 04/2006
4	Necrosis 01/2021 - 06/2004
4	Vasculitis (Vasculitides) 01/2021 - 05/2009
4	Lupus Nephritis 01/2020 - 09/2004
4	Pneumonia (Pneumonitis) 01/2018 - 06/2004
4	Hypersensitivity (Allergy) 02/2016 - 08/2003
4	Mandibular Fractures 01/2013 - 07/2010
4	Anaphylaxis (Anaphylactic Shock) 06/2011 - 03/2002
3	Neoplasm Metastasis (Metastasis) 09/2022 - 09/2008
3	Pain (Aches) 01/2021 - 08/2011
3	Osteoporosis 07/2020 - 09/2013
3	Drug-Related Side Effects and Adverse Reactions 03/2019 - 01/2014
3	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018 - 05/2009
3	Glomerulonephritis 12/2017 - 05/2007
3	Wounds and Injuries (Trauma) 10/2016 - 01/2011
3	Fibrosis (Cirrhosis) 04/2016 - 10/2005
3	Thrombotic Thrombocytopenic Purpura 11/2015 - 01/2011
3	Fever (Fevers) 01/2015 - 05/2013
3	Facial Injuries (Facial Injury) 01/2013 - 06/2011
3	Nephritis 11/2012 - 09/2007
3	Fanconi Anemia (Fanconi's Anemia) 03/2008 - 08/2003
3	Carcinogenesis 03/2008 - 09/2003
3	Allergic Rhinitis 01/2008 - 09/2006

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2002
27	CytokinesIBA 01/2021 - 03/2002
24	AutoantibodiesIBA 01/2022 - 08/2003
17	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2009
17	AntigensIBA 10/2016 - 07/2002
12	tocilizumab (atlizumab)FDA Link 05/2020 - 09/2007
12	HLA-DRB1 Chains (HLA DRB1)IBA 01/2019 - 01/2004
12	AutoantigensIBA 03/2016 - 02/2002
10	AntibodiesIBA 01/2022 - 01/2003
9	Certolizumab Pegol FDA Link 03/2020 - 07/2014
8	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 08/2003
7	EnzymesIBA 11/2022 - 08/2003
7	Rituximab (Mabthera)FDA Link 02/2021 - 01/2007
7	Peptides (Polypeptides)IBA 05/2015 - 08/2003
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 09/2002
6	InterleukinsIBA 01/2021 - 08/2002
6	Protein-Arginine DeiminasesIBA 01/2020 - 08/2003
6	Immunoglobulin E (IgE)IBA 10/2018 - 09/2005
6	Antirheumatic Agents (DMARD)IBA 09/2018 - 09/2007
6	Interleukin-10 (Interleukin 10)IBA 01/2018 - 06/2005
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2017 - 06/2004
5	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 10/2003
5	golimumab FDA Link 09/2018 - 06/2012
5	EpitopesIBA 01/2018 - 01/2004
5	Tacrolimus (Prograf)FDA LinkGeneric 12/2017 - 10/2011
5	Anti-Citrullinated Protein AntibodiesIBA 06/2016 - 12/2009
5	Interleukin-6 (Interleukin 6)IBA 08/2015 - 08/2002
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2024 - 11/2007
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 05/2009
4	Antigen-Antibody Complex (Immune Complex)IBA 01/2020 - 05/2007
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 06/2010
4	Immunoglobulin G (IgG)IBA 01/2019 - 04/2006
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2017 - 01/2004
4	acetyl 4-aminosalicylic acidIBA 04/2016 - 01/2011
4	Immunoglobulins (Immunoglobulin)IBA 03/2016 - 05/2007
4	Protein-Arginine Deiminase Type 4IBA 01/2016 - 11/2003
4	AllergensIBA 01/2013 - 09/2006
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2010 - 03/2007
4	micaIBA 08/2009 - 07/2007
4	OvalbuminIBA 01/2009 - 01/2004
4	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2009 - 08/2002
4	Nucleosomes (Nucleosome)IBA 10/2008 - 08/2004
4	Messenger RNA (mRNA)IBA 02/2006 - 08/2002
3	InterferonsIBA 01/2023 - 04/2003
3	Fc Receptors (Fc Receptor)IBA 01/2023 - 05/2005
3	HLA Antigens (Human Leukocyte Antigens)IBA 12/2022 - 01/2019
3	GlucocorticoidsIBA 07/2020 - 07/2019
3	anti-dsDNA autoantibodyIBA 01/2020 - 11/2012
3	iguratimodIBA 03/2019 - 05/2013
3	Interleukin-33IBA 01/2016 - 11/2008
3	thiamine triphosphorate (TTP)IBA 11/2015 - 01/2011
3	ElementsIBA 04/2014 - 09/2004
3	Interleukin-4 (Interleukin 4)IBA 01/2012 - 01/2004
3	cyclic citrullinated peptideIBA 01/2011 - 12/2009
3	Vascular Endothelial Growth Factor CIBA 08/2010 - 03/2007
3	CitrullineIBA 09/2008 - 11/2003
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 03/2008 - 08/2003

Therapy/Procedure

36	Therapeutics 11/2023 - 05/2004
5	Jaw Fixation Techniques 01/2013 - 07/2010
5	Immunotherapy 01/2008 - 01/2004
4	General Anesthesia 01/2021 - 08/2010
3	Tooth Extraction (Tooth Extractions) 01/2019 - 01/2016
3	Oral Administration 03/2016 - 02/2006